This is not the most recent version of the article. View current version (30 APR 2013)

Intervention Protocol

Nebuliser devices for drug delivery in cystic fibrosis

  1. Tracey Daniels1,*,
  2. Nicola Mills2,
  3. Paul Whitaker3

Editorial Group: Cochrane Cystic Fibrosis and Genetic Disorders Group

Published Online: 21 JAN 2009

Assessed as up-to-date: 10 NOV 2008

DOI: 10.1002/14651858.CD007639


How to Cite

Daniels T, Mills N, Whitaker P. Nebuliser devices for drug delivery in cystic fibrosis (Protocol). Cochrane Database of Systematic Reviews 2009, Issue 1. Art. No.: CD007639. DOI: 10.1002/14651858.CD007639.

Author Information

  1. 1

    York Teaching Hospital Foundation NHS Trust, York, UK

  2. 2

    Glenfield Hospital, Physiotherapy Department, Leicester, UK

  3. 3

    St James' Hospital, Regional Adult CF Unit, Ward 2, Gledhow Wing, Leeds, UK

*Tracey Daniels, York Teaching Hospital Foundation NHS Trust, Wiggington Road, York, YO31 8HE, UK. traceyhughes3@nhs.net.

Publication History

  1. Publication Status: Edited (no change to conclusions)
  2. Published Online: 21 JAN 2009

SEARCH

This is not the most recent version of the article. View current version (30 APR 2013)

 

Abstract

  1. Top of page
  2. Abstract

This is the protocol for a review and there is no abstract. The objectives are as follows:

To assess effectiveness, safety, burden of care and adherence to nebulised therapy using the different nebuliser devices available